Trial NCT01255163

View at ClinicalTrials.gov 
Org. Study IDs: 100423
Secondary IDs: 10-AG-0423

Last trial update was posted on 2018-02-22

MeSH Interventions

Exenatide

MeSH Conditions

Alzheimer Disease Cognitive Dysfunction

Other Conditions

Alzheimer's Disease Mild Cognitive Impairment

Stopping Reasons

AstraZeneca withdrew support for the study.

Limitations And Caveats

The study was terminated after AstraZeneca withdrew support. Early termination lead to small number of subjects analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID